MDMA and PTSD: A Conversation with Rick Doblin, Executive Director of MAPS
3,4-methylenedioxymethamphetamine is also known by its initials: MDMA, though it's better known to the public as Ecstasy. MDMA was first synthesized in the early 1900s in Germany, and began to be used in psychotherapy in the 1970s. In 1985 the Drug Enforcement Administration banned it, placing MDMA into Schedule One. A number of therapists and researchers feel that the DEA is wrong, and that the current schedule of drugs is based largely on misinformation, misunderstanding, and prejudice. One researcher who has been working for the past few decades to prove that MDMA is in fact a useful therapeutic drug is Rick Doblin. His professional goal is to help develop legal contexts for the beneficial uses of psychedelics and marijuana, primarily as prescription medicines but also for personal growth for otherwise healthy people.
CSDP Director of Research Doug McVay recorded this one-hour interview with Rick Doblin for public radio station KBOO in Portland, Oregon. It was originally broadcast on November 4, 2015.